The pen needles market size is projected to reach US$ 5.40 billion by 2031 from US$ 2.33 billion in 2023. The market is expected to register a CAGR of 11.1% during 2023–2031. Rising awareness about the self-administration of insulin therapy is are likely to remain key trends in the market.

Pen Needles Market Analysis

The rising prevalence of diabetes around the world is a major reason driving the growth of the pen needle market. Rising expenditure on healthcare infrastructure development, rising adoption of insulin injection pens over traditional syringes, as well as rising government initiatives to enhance the life sciences industry, are also driving the pen needles market. Other indirect contributors of pen needle market growth include an increasing geriatric population and personal disposable income.  Development of cost-efficient pen needles are expected to provide growth opportunities to emerging and local players in the global pen needles market.

Pen Needles Market Overview

Some of the factors driving the growth of this market include an increase in the diabetes population and increased awareness of the use of insulin pens. According to the Lancet, 529 million people globally had diabetes in 2021, with the vast majority living in low- and middle-income nations. The frequency and incidence of diabetes have increased during the last decade. Moreover, the World Health Organisation (WHO) has set a global aim of halting the rise in diabetes and obesity by 2025.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Pen Needles Market: Strategic Insights

Pen Needles Market

• 
  CAGR (2023 - 2031)

  11.1%
• Market Size 2023
  US$ 2.33 Billion
• Market Size 2031
  US$ 5.40 Billion

Market Dynamics

GROWTH DRIVERS

• Rise in Number of Patients Suffering from Diabetes

FUTURE TRENDS

• Rising Adoption of Insulin Injection Pens Over Traditional Syringes and Vials

OPPORTUNITIES

• Increasing Launch of GLP-1 Analogues

Key Players

• BD
• NOVO NORDISK A/S
• YPSOMED AG
• B. Braun Melsungen AG
• Owen Mumford Ltd
• HTL-Strefa S.A.
• Ultimed Inc
• Terumo Corporation
• Allison Medical Inc
• Artsana S.p.A.

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Type

• Standard Pen Needles
• Safety Pen Needles

Therapy

• Insulin Therapy
• GLP-1 Therapy
• Growth Hormone Therapy

Length

• 4mm
• 5mm
• 6mm
• 8mm
• 10mm
• 12mm

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Pen Needles Market Drivers and Opportunities

Rising Adoption of Insulin Injection Pens Over Traditional Syringes and Vials to Favor Market

In recent years, there has been a considerable developments in the field of medical drug delivery devices. Insulin administration is a common procedure in diabetic population. pen needles that have emerged as a solution to combat all the existing issues of the needles and vials for drug delivery offer several advantages that has led to rapid shift of patients’ preference towards their use. The injection pens that facilitates easy attachment and retraction of pen needles does not need a skill set and require fewer steps than that of syringes and vials. Moreover, the availability of pen needles in different lengths as well as gauge sizes provide variety of options to the users to find the best suitable option according to their needs. Thus, the inclination of patients towards pen needles used in injection pens over syringes is expected to be a driving factor to foster the growth of pen needles market.

Increasing Launch of GLP-1 Analogues

Glucagon like Peptide-1 also known as GLP-1 is a hormone produced in the gut that is released in response to the food consumed by an individual. The peptide reduces the appetite of an individual and helps to secrete insulin in the body among obese patients. In recent years, external injection of GLP-1 has been witnessing a significant traction due to increase in the number of doctor prescription for these hormones. The rising number of novel GLP-1 analogue launches is thus expected to indirectly provide opportunities for the manufacturers to develop therapy specific pen needles with incorporation of features such as bore size, length and material that is not reactive with the biologic.

Pen Needles Market Report Segmentation Analysis

Key segments that contributed to the derivation of the pen needles market analysis are type, therapy, and length.

• Based on type, the pen needles market is bifurcated into standard pen needles and safety pen needles. The standard pen needles segment held a larger market share in 2023.
• By cause, the market is segmented into insulin therapy, GLP-1 therapy, and growth hormone therapy. The insulin therapy segment held the largest share of the market in 2023.
• In terms of category, the market is segmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. The 4mm segment held the largest share of the market in 2023.

Pen Needles Market Share Analysis by Geography

The geographic scope of the pen needles market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the market. Increasing geriatric population, rising prevalence of diabetes, favourable reimbursement for diabetes care consumables and supplies, increasing healthcare expenditure, advancement in the technological developments, and the major presence of the key players in this market is going to propel the market growth.

Pen Needles Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Pen Needles Market News and Recent Developments

The pen needles market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the pen needles market are listed below:

• The U.S. Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) injection, Eli Lilly and Company's new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. (Source: Eli Lilly and Company, Press Release, May 2022)

Pen Needles Market Report Coverage and Deliverables

The “Pen Needles Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Pen needles market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Pen needles market trends as well as market dynamics such as drivers, restraints, and key opportunities
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Pen needles market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the pen needles market
• Detailed company profiles